261 related articles for article (PubMed ID: 33560612)
1. [Pharmacotherapy for obesity].
van Rossum EFC; Welling MS; van der Voorn B; van der Valk ES; Abawi O; van den Akker ELT
Ned Tijdschr Geneeskd; 2021 Jan; 165():. PubMed ID: 33560612
[TBL] [Abstract][Full Text] [Related]
2. New-generation anti-obesity drugs: naltrexone/bupropion and liraglutide. An update for endocrinologists and nutritionists.
Barrea L; Pugliese G; Muscogiuri G; Laudisio D; Colao A; Savastano S
Minerva Endocrinol; 2020 Jun; 45(2):127-137. PubMed ID: 32643356
[TBL] [Abstract][Full Text] [Related]
3. Melatonin, Liraglutide, and Naltrexone/Bupropion for the Treatment of Obesity and Medication-Related Weight Gain.
Howland RH
J Psychosoc Nurs Ment Health Serv; 2015 Jun; 53(6):19-22. PubMed ID: 26091546
[TBL] [Abstract][Full Text] [Related]
4. The Role of Antiobesity Agents in the Management of Polycystic Ovary Syndrome.
Chatzis P; Tziomalos K; Pratilas GC; Makris V; Sotiriadis A; Dinas K
Folia Med (Plovdiv); 2018 Dec; 60(4):512-520. PubMed ID: 31188761
[TBL] [Abstract][Full Text] [Related]
5. Overview of new antiobesity drugs.
Hainer V
Expert Opin Pharmacother; 2014 Oct; 15(14):1975-8. PubMed ID: 25100293
[TBL] [Abstract][Full Text] [Related]
6. Pharmacotherapy for obesity: What you need to know.
Bersoux S; Byun TH; Chaliki SS; Poole KG
Cleve Clin J Med; 2017 Dec; 84(12):951-958. PubMed ID: 29244650
[TBL] [Abstract][Full Text] [Related]
7. Obesity Epidemic: Pharmaceutical Weight Loss.
Curry SA
R I Med J (2013); 2017 Mar; 100(2):18-20. PubMed ID: 28246654
[TBL] [Abstract][Full Text] [Related]
8. Association of Pharmacological Treatments for Obesity With Weight Loss and Adverse Events: A Systematic Review and Meta-analysis.
Khera R; Murad MH; Chandar AK; Dulai PS; Wang Z; Prokop LJ; Loomba R; Camilleri M; Singh S
JAMA; 2016 Jun; 315(22):2424-34. PubMed ID: 27299618
[TBL] [Abstract][Full Text] [Related]
9. A Comparison of New Pharmacological Agents for the Treatment of Obesity.
Nuffer W; Trujillo JM; Megyeri J
Ann Pharmacother; 2016 May; 50(5):376-88. PubMed ID: 26887340
[TBL] [Abstract][Full Text] [Related]
10. Gender-related issues in the pharmacology of new anti-obesity drugs.
Cataldi M; Muscogiuri G; Savastano S; Barrea L; Guida B; Taglialatela M; Colao A
Obes Rev; 2019 Mar; 20(3):375-384. PubMed ID: 30589980
[TBL] [Abstract][Full Text] [Related]
11. Obesity Pharmacotherapy.
Saunders KH; Umashanker D; Igel LI; Kumar RB; Aronne LJ
Med Clin North Am; 2018 Jan; 102(1):135-148. PubMed ID: 29156182
[TBL] [Abstract][Full Text] [Related]
12. Current and emerging pharmacotherapies for obesity in Australia.
Hocking S; Dear A; Cowley MA
Obes Res Clin Pract; 2017; 11(5):501-521. PubMed ID: 28818558
[TBL] [Abstract][Full Text] [Related]
13. Naltrexone/bupropion for the treatment of obesity and obesity with Type 2 diabetes.
Apovian CM
Future Cardiol; 2016 Mar; 12(2):129-38. PubMed ID: 26679384
[TBL] [Abstract][Full Text] [Related]
14. The relationship between early weight loss and weight loss at 1 year with naltrexone ER/bupropion ER combination therapy.
Fujioka K; Plodkowski R; O'Neil PM; Gilder K; Walsh B; Greenway FL
Int J Obes (Lond); 2016 Sep; 40(9):1369-75. PubMed ID: 27328752
[TBL] [Abstract][Full Text] [Related]
15. Pharmacological Treatment for Obesity in Adults: An Umbrella Review.
Khalil H; Ellwood L; Lord H; Fernandez R
Ann Pharmacother; 2020 Jul; 54(7):691-705. PubMed ID: 31958967
[No Abstract] [Full Text] [Related]
16. A health economic model to assess the cost-effectiveness of OPTIFAST for the treatment of obesity in the United States.
Nuijten M; Marczewska A; Araujo Torres K; Rasouli B; Perugini M
J Med Econ; 2018 Sep; 21(9):835-844. PubMed ID: 29678127
[TBL] [Abstract][Full Text] [Related]
17. Practical Use of Pharmacotherapy for Obesity.
Igel LI; Kumar RB; Saunders KH; Aronne LJ
Gastroenterology; 2017 May; 152(7):1765-1779. PubMed ID: 28192104
[TBL] [Abstract][Full Text] [Related]
18. Beyond lifestyle interventions: exploring the potential of anti-obesity medications in the UK.
Wilding JPH
Clin Obes; 2018 Jun; 8(3):211-225. PubMed ID: 29689646
[TBL] [Abstract][Full Text] [Related]
19. Combination therapy for obesity.
Wilding JP
J Psychopharmacol; 2017 Nov; 31(11):1503-1508. PubMed ID: 29132230
[TBL] [Abstract][Full Text] [Related]
20. Combination Therapies for Obesity.
Camilleri M; Acosta A
Metab Syndr Relat Disord; 2018 Oct; 16(8):390-394. PubMed ID: 29993319
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
